Gal-1 stimulates T cells to increase the production of Th2 cytokines, such as IL-4, IL-5, IL-10, and IL-13, which may help mitigate autoimmune diseases during in vivo treatments [240, 242, 244]. Here, LGALS1 is linked to autoimmune disease.